Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -531.0% | n/a |
ROCE | 38962.2% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 7.6 | n/a |
Pr/Book | 2.2 |
Latest | F'cast | |
---|---|---|
Revenue | 8.3% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 0.52 | (0.45) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 0.22 | (0.95) | (1.36)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 0.54 | (2.70) | (2.61)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 0.59 | (3.12) | (3.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Research Agreement | 15-Oct-2024 | 07:00 | RNS |
Research and development update | 04-Oct-2024 | 07:00 | RNS |
Directorate Change and grant of options | 26-Sep-2024 | 07:00 | RNS |
No recent information was found.
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.20p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.30 |
52 Week Low | 0.12 |
Volume | 52,935,786 |
Shares Issued | 2,295.93m |
Market Cap | £4.48m |
Beta | 0.81 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:10 | 6,957,519 @ 0.19p |
15:43 | 143,471 @ 0.20p |
14:28 | 3,600,000 @ 0.19p |
15:26 | 475,813 @ 0.19p |
13:07 | 7,750,000 @ 0.20p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
You are here: research